Memantine Mylan
- Prescription status not stated
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Memantine
- Made by
- Mylan Pharmaceuticals Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of patients with moderate to severe Alzheimer’s disease.
From the official label · 2026-09-30 · European Medicines Agency
How it works
From the US prescribing label for the same active substance (memantine hydrochloride). It describes the substance, not this exact product.
Persistent activation of central nervous system N-methyl-D-aspartate (NMDA) receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease.
Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels.
Effect of Memantine Hydrochloride on the Metabolism of Other Drugs In vitro studies conducted with marker substrates of CYP450 enzymes (CYP1A2, -2A6, -2C9, 2D6, -2E1, -3A4) showed minimal inhibition of these enzymes by memantine.
Food has no effect on the absorption of memantine.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-20
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Mylan Pharmaceuticals Limited |
|---|---|
| Active substance | Memantine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Classification | N06DX01 · Pain, sleep, mood, epilepsy and the brain |
| Generic | Yes — a generic medicine, according to the register |
| Authorised on | 2013-04-21 |
| Last updated by the regulator | 2025-11-28 |
| EMA product number | EMEA/H/C/002660 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.